On Comprehensive Mass Spectrometry Data Analysis for Proteome Profiling of Human Blood Samples

被引:0
作者
Manchanda S. [1 ]
Meyer M. [2 ]
Li Q. [3 ]
Liang K. [3 ]
Li Y. [3 ]
Kong N. [4 ]
机构
[1] Department of Computer Science, Purdue University, West Lafayette
[2] Department of Statistics and Mathematics, Purdue University, West Lafayette, IN
[3] Institute of Biophysics, Chinese Academy of Sciences, Beijing
[4] Weldon School of Biomedical Engineering, Purdue University, 206 S. Martin Jischke Dr, West Lafayette, 47906, IN
基金
美国国家科学基金会;
关键词
Binary classification; Blood sample; Feature ranking; Mass spectrometry; Proteome profiling;
D O I
10.1007/s41666-018-0022-0
中图分类号
学科分类号
摘要
To guarantee meaningful interpretation of data in basic and translational medicine, it is critical to ensure the quality of biological samples. Mass spectrometers have become promising instruments to acquire proteomic information that is known to be associated with the quality of samples. However, a universally applicable mass spectrometry data analysis platform for quality assessment remains of great need. We present a comprehensive pattern recognition study to facilitate the development of such a platform. This study involves feature extraction, binary classification, and feature ranking. In this study, we develop classifiers with classification accuracy higher than 90% in distinguishing human serum samples stored for different amounts of time. We also derive fingerprint patterns of serum peptides that can be conveniently used for temporal classification. © 2018, Springer International Publishing AG, part of Springer Nature.
引用
收藏
页码:305 / 318
页数:13
相关论文
共 30 条
[11]  
Kozak K.R., Et al., Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis, Proc Natl Acad Sci, 100, 21, pp. 12343-12348, (2003)
[12]  
Levner I., Feature selection and nearest centroid classification for protein mass spectrometry, BMC Bioinformatics, 6, 1, (2005)
[13]  
Liang K., Et al., Mesoporous silica chip: enabled peptide profiling as an effective platform for controlling bio-sample quality and optimizing handling procedure, Clin Proteomics, 13, 1, (2016)
[14]  
Ostroff R., Et al., The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array, J Proteomics, 73, 3, pp. 649-666, (2010)
[15]  
Papadopoulos M.C., Et al., A novel and accurate diagnostic test for human African trypanosomiasis, Lancet, 363, 9418, pp. 1358-1363, (2004)
[16]  
Petricoin E.F., Et al., Use of proteomic patterns in serum to identify ovarian cancer, Lancet, 359, 9306, pp. 572-577, (2002)
[17]  
Pieragostino D., Petrucci F., Del Boccio P., Mantini D., Lugaresi A., Tiberio S., Onofrj M., Gambi D., Sacchetta P., Di Ilio C., Federici G., Urbani A., Pre-analytical factors in clinical proteomics investigations: Impact of ex vivo protein modifications for multiple sclerosis biomarker discovery, Journal of Proteomics, 73, 3, pp. 579-592, (2010)
[18]  
Rai A.J., Et al., HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples, Proteomics, 5, 13, pp. 3262-3277, (2005)
[19]  
Russell S.J., Et al., Artificial intelligence: a modern approach. Vol. 2, (2003)
[20]  
Sorace J.M., Zhan M., A data review and re-assessment of ovarian cancer serum proteomic profiling, BMC Bioinformatics, 4, 1, (2003)